24 results
CORRESP
GLTO
Galecto Inc
20 Oct 20
Correspondence with SEC
12:00am
as a result of the COVID-19 pandemic resulting in higher market volatility and investor uncertainty.
ii. Although the NASDAQ biotechnology index … trial during this period, experienced patient enrollment delays due to the COVID-19 pandemic. These delays resulted in concerns regarding the Company’s
10-Q
o0p7iak vgbyt5d
11 Dec 20
Quarterly report
7:30am
10-K
5pvbv55fu882fdcj
29 Mar 21
Annual report
6:03am
424B4
7jeuf
30 Oct 20
Prospectus supplement with pricing info
4:31pm
S-1
21xi5q1 cem65s3z7s0
7 Oct 20
IPO registration
5:01pm
S-1/A
9o5aruwxmwhusqq0
22 Oct 20
IPO registration (amended)
6:13am
DRS
7mxz4ib
2 Sep 20
Draft registration statement
12:00am
UPLOAD
etwhtwnm5diy8hza3
29 Sep 20
Letter from SEC
12:00am
CORRESP
e3jrw vk8h6m4wv
13 Oct 20
Correspondence with SEC
12:00am
8-K
EX-99.1
717088uau p5qis
5 Jan 21
Results of Operations and Financial Condition
4:31pm
8-K
EX-99.1
d2uqbzy tc
5 Jan 22
Regulation FD Disclosure
4:02pm
8-K
EX-10.1
06vzw h63hv31aoe
6 Jul 21
Departure of Directors or Certain Officers
9:00am